
The Federal Trade Commission (FTC) could reportedly rule on Microsoft‘s proposed acquisition of Activision Blizzard by late November.
That’s according to Seeking Alpha, which claims the US regulator’s inquiry is still at the staff level, but that it’s expected to progress through the Bureau of Competition and onto the commissioners over the coming weeks.
The publication’s sources claim FTC staff have significant concerns about the $68.7 billion merger, and that the regulator has been engaging with a number of competitors opposed to the transaction, including Sony and Google.
The Information reported in April that the FTC’s investigation into the deal was likely to focus on the consumer data that both companies hold as well as its potential impact on the labour market.
It also said the FTC would review the deal’s potential impact on workers who have accused Activision of harassment and discrimination, as well its potential impact on the competitive metaverse.
The acquisition is currently being scrutinised by regulators around the world amid antitrust concerns during a time of increasing consolidation in the gaming industry.
The UK competition regulator announced on Tuesday that it has set a deadline of March 1, 2023 to publish the findings of its inquiry into the deal.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas